AUTL
Price
$2.35
Change
-$0.05 (-2.08%)
Updated
Aug 1 closing price
Capitalization
625.42M
10 days until earnings call
LRMR
Price
$3.44
Change
-$0.02 (-0.58%)
Updated
Aug 1 closing price
Capitalization
219.94M
5 days until earnings call
Interact to see
Advertisement

AUTL vs LRMR

Header iconAUTL vs LRMR Comparison
Open Charts AUTL vs LRMRBanner chart's image
Autolus Therapeutics
Price$2.35
Change-$0.05 (-2.08%)
Volume$1.35M
Capitalization625.42M
Larimar Therapeutics
Price$3.44
Change-$0.02 (-0.58%)
Volume$1.16M
Capitalization219.94M
AUTL vs LRMR Comparison Chart in %
Loading...
AUTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AUTL vs. LRMR commentary
Aug 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AUTL is a Hold and LRMR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 02, 2025
Stock price -- (AUTL: $2.35 vs. LRMR: $3.46)
Brand notoriety: AUTL and LRMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AUTL: 75% vs. LRMR: 147%
Market capitalization -- AUTL: $625.42M vs. LRMR: $219.94M
AUTL [@Biotechnology] is valued at $625.42M. LRMR’s [@Biotechnology] market capitalization is $219.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $213.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AUTL’s FA Score shows that 0 FA rating(s) are green whileLRMR’s FA Score has 1 green FA rating(s).

  • AUTL’s FA Score: 0 green, 5 red.
  • LRMR’s FA Score: 1 green, 4 red.
According to our system of comparison, both AUTL and LRMR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AUTL’s TA Score shows that 3 TA indicator(s) are bullish while LRMR’s TA Score has 3 bullish TA indicator(s).

  • AUTL’s TA Score: 3 bullish, 5 bearish.
  • LRMR’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both AUTL and LRMR are a bad buy in the short-term.

Price Growth

AUTL (@Biotechnology) experienced а -6.75% price change this week, while LRMR (@Biotechnology) price change was -7.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.14%. For the same industry, the average monthly price growth was +15.55%, and the average quarterly price growth was +36.18%.

Reported Earning Dates

AUTL is expected to report earnings on Oct 30, 2025.

LRMR is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+0.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AUTL($625M) has a higher market cap than LRMR($220M). AUTL YTD gains are higher at: 0.000 vs. LRMR (-11.111). LRMR has higher annual earnings (EBITDA): -105.02M vs. AUTL (-226.02M). AUTL has more cash in the bank: 517M vs. LRMR (158M). LRMR has less debt than AUTL: LRMR (4.87M) vs AUTL (57.7M). AUTL has higher revenues than LRMR: AUTL (9.01M) vs LRMR (0).
AUTLLRMRAUTL / LRMR
Capitalization625M220M284%
EBITDA-226.02M-105.02M215%
Gain YTD0.000-11.111-
P/E RatioN/AN/A-
Revenue9.01M0-
Total Cash517M158M327%
Total Debt57.7M4.87M1,186%
FUNDAMENTALS RATINGS
AUTL vs LRMR: Fundamental Ratings
AUTL
LRMR
OUTLOOK RATING
1..100
6020
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
22
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
4048
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LRMR's Valuation (22) in the null industry is in the same range as AUTL (40) in the Biotechnology industry. This means that LRMR’s stock grew similarly to AUTL’s over the last 12 months.

LRMR's Profit vs Risk Rating (100) in the null industry is in the same range as AUTL (100) in the Biotechnology industry. This means that LRMR’s stock grew similarly to AUTL’s over the last 12 months.

AUTL's SMR Rating (96) in the Biotechnology industry is in the same range as LRMR (100) in the null industry. This means that AUTL’s stock grew similarly to LRMR’s over the last 12 months.

AUTL's Price Growth Rating (40) in the Biotechnology industry is in the same range as LRMR (48) in the null industry. This means that AUTL’s stock grew similarly to LRMR’s over the last 12 months.

AUTL's P/E Growth Rating (100) in the Biotechnology industry is in the same range as LRMR (100) in the null industry. This means that AUTL’s stock grew similarly to LRMR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AUTLLRMR
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 10 days ago
82%
Bullish Trend 10 days ago
86%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
AUTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EKJFX15.13N/A
N/A
Allspring Premier Large Co Gr R6
PMFYX12.50N/A
N/A
Victory Pioneer Multi-Asset Income Y
EPDPX11.50N/A
N/A
EuroPac International Dividend Income A
RISRX13.97N/A
N/A
RBC International Small Cap Equity R6
PXWGX24.16-0.34
-1.39%
Impax US Sustainable Economy Investor

LRMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LRMR has been loosely correlated with ERAS. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if LRMR jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LRMR
1D Price
Change %
LRMR100%
-0.58%
ERAS - LRMR
52%
Loosely correlated
-1.77%
SYRE - LRMR
51%
Loosely correlated
-4.18%
EYPT - LRMR
49%
Loosely correlated
-1.12%
ALEC - LRMR
48%
Loosely correlated
-2.68%
ACLX - LRMR
48%
Loosely correlated
-0.35%
More